BMRN Competitors & Alternatives
Compare Biomarin Pharmaceutical Inc with similar stocks in the same industry
Biotechnology
BMRN
Main Stock$56.70
Tradestie Score
53
Market Cap
$10.53B
Revenue Growth
0.3%
Analyst Upside
+60.1%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$267.07
|
$12.36B | 19.9 | 36 | Compare |
|
EXEL
Exelixis Inc
|
$69.84
|
$11.09B | 21.2 | 27 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$39.99
|
$10.76B | - | 31 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$231.35
|
$10.74B | - | 39 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$27.31
|
$10.49B | - | 45 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$78.17
|
$10.22B | - | 30 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$425.21
|
$10.01B | - | 58 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.84
|
$9.33B | 66.8 | 50 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$73.71
|
$8.88B | 55.2 | 56 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$100.67
|
$8.77B | 25.7 | 55 | Compare |
More BMRN Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry